SCHEMBL14147697

SCHEMBL14147697

CCC(=O)Nc1ccc([C@@H](C)N)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
MAPT P10636 2/20 0.54
ATM Q13315 1/20 0.54
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
TSHR P16473 1/20 0.53
ALDH1A1 P00352 4/20 0.51
RAB9A P51151 3/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 1/20 0.51
ROCK2 O75116 2/20 0.50
ROCK1 Q13464 2/20 0.50
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
NPC1 O15118 2/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP3A4 P08684 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13141364 0.86 SMN1; SMN2 (0.50) CA1CA2MAPTGAASMN1; SMN2
SCHEMBL104611 0.85 SMN1; SMN2 (0.67) CA12CA1CA2CA9MAPT
SCHEMBL13989319 0.82 GAA (0.73) CA12CA1CA2CA9MAPT
SCHEMBL14237971 0.82 TSHR (0.76) CA12CA1CA2CA9MAPT
SCHEMBL28441128 0.80 MAPT (0.56) CA12CA1CA2CA9MAPT
SCHEMBL8643836 0.79 SMN1; SMN2 (0.57) CA12CA1CA2CA9MAPT
SCHEMBL8648800 0.79 SMN1; SMN2 (0.57) CA12CA1CA2CA9MAPT
SCHEMBL4579197 0.79 SMN1; SMN2 (0.57) CA12CA1CA2CA9MAPT
SCHEMBL11989525 0.79 ALDH1A1 (0.53) CA12CA1CA2CA9MAPT
SCHEMBL28897295 0.79 MAPT (0.64) CA12CA1CA2CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079346-A1 5-CYAN0-4- (PYRROLO [2, 3B] PYRIDINE-3-YL) -PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-07-03 WO disclosed